Effectdossier · gearchiveerd kwartaal
CGEM
Cullinan Therapeutics, Inc. · Healthcare · Biotechnology
65Gevolgde houders
+1Δ houders
21.69MGehouden aandelen
$224.52MGerapporteerde waarde
+1Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +1.6% ·
aandelenstroom +1.4% ·
netto nieuwe posities +1.5%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 10.21K | $157,847 | n/a | −1 |
| Q2 2026 | 77 | +7 | 28.05M | $510.52M | +11 | −4 |
| Q1 2026 | 73 | +7 | 24.59M | $348.81M | +10 | −3 |
| Q4 2025 | 65 | +1 | 21.69M | $224.52M | +1 | n/a |
| Q3 2025 | 17 | +1 | 15.39M | $91.26M | +1 | n/a |
| Q2 2025 | 13 | 0 | 14.48M | $109.06M | +1 | −1 |
| Q1 2025 | 10 | -1 | 7.69M | $58.25M | n/a | −1 |
| Q4 2024 | 11 | 0 | 8.98M | $109.41M | n/a | n/a |
| Q3 2024 | 10 | +1 | 6.86M | $114.80M | +1 | n/a |
| Q2 2024 | 9 | n/a | 7.12M | $124.19M | n/a | n/a |
Wie het bezit · Q4 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 4.40M | +5.5% | $45.54M | 0.0% | ▲ Add | 3 | SEC ↗ ×11 |
| 2 | The Vanguard Group ✦ (passief) | 3.30M | +12.1% | $34.14M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 2.20M | +31.0% | $22.74M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 1.30M | +0.5% | $13.48M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 5 | Dimensional Fund Advisors Lp | 848.77K | n/a | $8.78M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 6 | Morgan Stanley ✦ | 766.93K | +91.7% | $7.94M | 0.0% | ▲ Add | 2 | SEC ↗ ×8 |
| 7 | Goldman Sachs Group ✦ | 721.86K | -26.6% | $7.47M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 8 | Renaissance Technologies ✦ | 631.71K | +19.3% | $6.54M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 9 | Deutsche Bank Ag\ | 586.64K | n/a | $6.07M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Nuveen, LLC | 579.10K | n/a | $5.99M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Two Sigma Investments ✦ | 470.53K | +688.5% | $4.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Charles Schwab Investment… | 436.27K | n/a | $4.52M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Northern Trust Corp | 421.63K | n/a | $4.36M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 14 | Marshall Wace ✦ | 414.36K | +40.2% | $4.29M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 15 | Millennium Management ✦ | 362.50K | -34.1% | $3.75M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 360.16K | Nieuw | $3.73M | 0.0% | New | 1 | SEC ↗ |
| 17 | Bank Of America Corp /De/ | 346.31K | n/a | $3.58M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 18 | AQR Capital Management ✦ | 281.48K | +42.2% | $2.91M | 0.0% | ▲ Add | 3 | SEC ↗ ×6 |
| 19 | UBS Group AG | 271.74K | n/a | $2.81M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 20 | Barclays Plc | 269.65K | n/a | $2.79M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 21 | Connor, Clark & Lunn Investment… | 244.02K | n/a | $2.53M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Citigroup Inc | 240.46K | n/a | $2.49M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 23 | Jane Street Group, Llc | 186.84K | n/a | $1.93M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 24 | Wellington Management ✦ | 159.75K | -5.0% | $1.65M | 0.0% | ▼ Trim | 7 | SEC ↗ ×3 |
| 25 | Assenagon Asset Management S.A. | 158.75K | n/a | $1.64M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 147.06K | +130.7% | $1.52M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 27 | Bank of New York Mellon Corp | 144.93K | n/a | $1.50M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 28 | American Century Companies Inc | 142.76K | n/a | $1.48M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Invesco Ltd. | 130.32K | n/a | $1.35M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 30 | Qube Research & Technologies Ltd | 119.29K | n/a | $1.23M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 110.32K | -94.4% | $1.14M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 32 | Hrt Financial Lp | 84.07K | n/a | $870,000 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Squarepoint Ops LLC | 75.82K | n/a | $784,737 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Rhumbline Advisers | 67.24K | n/a | $695,924 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Wells Fargo & Company/Mn | 60.51K | n/a | $626,320 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Swiss National Bank | 58.30K | n/a | $603,405 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Mariner, LLC | 49.13K | n/a | $508,208 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | UBS AM, a distinct business unit of… | 48.05K | n/a | $497,328 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 39 | Quantinno Capital Management LP | 48.00K | n/a | $496,810 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Alliancebernstein L.P. | 47.63K | n/a | $492,971 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | T. Rowe Price ✦ | 47.19K | +9.1% | $489,000 | 0.0% | ▲ Add | 7 | SEC ↗ |
| 42 | Creative Planning | 39.89K | n/a | $412,862 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Susquehanna International Group, Llp | 39.82K | n/a | $412,158 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Bnp Paribas Financial Markets | 39.45K | n/a | $408,318 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | California State Teachers… | 30.80K | n/a | $318,770 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Legal & General Group Plc | 28.63K | n/a | $296,299 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 47 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 28.66K | n/a | $295,073 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 48 | Russell Investments Group, Ltd. | 24.41K | n/a | $252,631 | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 49 | Janus Henderson Group Plc | 18.53K | n/a | $191,394 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Manufacturers Life Insurance… | 16.82K | n/a | $174,108 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | D. E. Shaw & Co. ✦ | 14.37K | -43.9% | $148,678 | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 52 | Simplex Trading, Llc | 13.25K | n/a | $137,168 | 0.0% | n/c | 1 | SEC ↗ |
| 53 | New York State Common Retirement… | 12.92K | n/a | $133,701 | 0.0% | n/c | 1 | SEC ↗ |
| 54 | ProShare Advisors LLC | 12.49K | n/a | $129,261 | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Tudor Investment Corp Et Al | 10.13K | n/a | $104,825 | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Zurcher Kantonalbank (Zurich… | 9.91K | n/a | $102,558 | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Fidelity (FMR) ✦ | 4.60K | +375.0% | $47,586 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 58 | Cwm, Llc | 3.88K | n/a | $40,000 | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Mirae Asset Global Investments Co.… | 2.87K | n/a | $29,715 | 0.0% | n/c | 1 | SEC ↗ |
| 60 | Royal Bank Of Canada | 1.55K | n/a | $16,000 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 61 | Us Bancorp \De\ | 483 | n/a | $4,999 | 0.0% | n/c | 1 | SEC ↗ |
| 62 | Osaic Holdings, Inc. | 243 | n/a | $2,515 | 0.0% | n/c | 1 | SEC ↗ |
| 63 | Optiver Holding B.V. | 200 | n/a | $2,070 | 0.0% | n/c | 1 | SEC ↗ |
| 64 | Daiwa Securities Group Inc. | 218 | n/a | $2,000 | 0.0% | n/c | 1 | SEC ↗ |
| 65 | Pnc Financial Services Group, Inc. | 5 | n/a | $52 | 0.0% | n/c | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Point72 Asset Management | $3.73M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 172 houders, 65.27M aandelen, $895.39M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Sep 08
Michaelson Jennifer
Officer · 8.00K aand · $172,560
Aug 13
Michaelson Jennifer
Officer · 30.00K aand · $607,800
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
Aug 14
SC 13G/A: BIOTECHNOLOGY VALUE FUND L P
Aug 14
SC 13G: PRICE T ROWE ASSOCIATES INC /MD/
Aug 07
SC 13G: STATE STREET CORP
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q4 2025 ·
Methodologie ·
Verkrijg dit via de API